OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
TPGC58

Top Glove Corporation Bhd

Medical Equipment, Supplies & DistributionVerified

Top Glove Corporation Bhd maintains a conservative capital structure, with a debt-to-equity ratio of 0.18, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.7, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which may signal potential liquidity constraints. In terms of profitability, Top Glove's return on equity (ROE) is 2.7%, and its return on assets (ROA) is 2.05%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming relative to its peers in terms of generating returns from equity and total assets. The company's revenue is primarily concentrated in the healthcare and industrial sectors, with a significant portion derived from glove manufacturing and distribution. While the input data does not provide a breakdown of geographic exposure, the company's operations are likely concentrated in Asia, given its listing on the Bursa Malaysia and its primary market presence. Top Glove's growth trajectory appears to be modest, with no specific numeric deltas provided for the current or next fiscal year. The company's operating cash flow of MYR 300.74 million and free cash flow of MYR 290.14 million suggest it has the capacity to fund operations and potentially reinvest in the business. However, the capital expenditure of MYR -138.92 million indicates a reduction in investment in new assets, which may affect long-term growth prospects. The company's risk profile is characterized by a low dilution potential, with no significant dilution sources identified in the input data. The risk assessment indicates a medium liquidity risk, primarily due to the negative net cash position after subtracting total debt. No recent events, such as filings or transcripts, are provided in the input data to further assess the company's risk environment.

30-day price · TPGC-0.01 (-0.6%)
Low$0.70High$0.88Close$0.80As of22 May, 00:00 UTC
Profile
CompanyTop Glove Corporation Bhd
TickerTPGC.KL
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Top Glove Corporation Bhd is a manufacturer and distributor of gloves, primarily serving the healthcare and industrial sectors.

Classification. Top Glove is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

Top Glove Corporation Bhd maintains a conservative capital structure, with a debt-to-equity ratio of 0.18, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.7, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which may signal potential liquidity constraints. In terms of profitability, Top Glove's return on equity (ROE) is 2.7%, and its return on assets (ROA) is 2.05%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming relative to its peers in terms of generating returns from equity and total assets. The company's revenue is primarily concentrated in the healthcare and industrial sectors, with a significant portion derived from glove manufacturing and distribution. While the input data does not provide a breakdown of geographic exposure, the company's operations are likely concentrated in Asia, given its listing on the Bursa Malaysia and its primary market presence. Top Glove's growth trajectory appears to be modest, with no specific numeric deltas provided for the current or next fiscal year. The company's operating cash flow of MYR 300.74 million and free cash flow of MYR 290.14 million suggest it has the capacity to fund operations and potentially reinvest in the business. However, the capital expenditure of MYR -138.92 million indicates a reduction in investment in new assets, which may affect long-term growth prospects. The company's risk profile is characterized by a low dilution potential, with no significant dilution sources identified in the input data. The risk assessment indicates a medium liquidity risk, primarily due to the negative net cash position after subtracting total debt. No recent events, such as filings or transcripts, are provided in the input data to further assess the company's risk environment.
Key takeaways
  • Top Glove has a conservative capital structure with a low debt-to-equity ratio of 0.18.
  • The company's ROE and ROA are below the industry median, indicating underperformance in generating returns.
  • Revenue is primarily concentrated in the healthcare and industrial sectors.
  • The company's liquidity position is medium, with a current ratio of 2.7.
  • Growth prospects may be limited due to reduced capital expenditure and no specific growth targets provided.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$3.49B
Gross profit$496.9M
Operating income$172.0M
Net income$128.4M
R&D
SG&A
D&A
SBC
Operating cash flow$300.7M
CapEx-$138.9M
Free cash flow$290.1M
Total assets$6.28B
Total liabilities$1.53B
Total equity$4.75B
Cash & equivalents
Long-term debt$849.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.75B
Net cash-$849.9M
Current ratio2.7
Debt/Equity0.2
ROA2.1%
ROE2.7%
Cash conversion2.3%
CapEx/Revenue-4.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricTPGCActivity
Op margin4.9%3.9% medp25 -31.3% · p75 14.4%above median
Net margin3.7%2.4% medp25 -30.5% · p75 11.1%above median
Gross margin14.2%46.7% medp25 28.2% · p75 63.1%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.0%-4.8% medp25 -11.6% · p75 -2.4%above median
Debt / equity18.0%17.9% medp25 2.7% · p75 52.2%above median
Observations
IR observations
Mean price target0.69 MYR
Median price target0.68 MYR
High price target0.90 MYR
Low price target0.50 MYR
Mean recommendation2.78 (1=strong buy, 5=strong sell)
Strong-buy count3.00
Buy count4.00
Hold count7.00
Sell count2.00
Strong-sell count2.00
Mean EPS estimate0.02 MYR
Last actual EPS0.01 MYR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 01:22 UTC#baf934c9
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 18:36 UTCJob: b58a0de4